Gore recently announced the first implantation of the investigational Gore ascending stent graft in the ARISE III trial for the treatment of an acute type A dissection @WLGorevascularnews.com/arise-iii-pivo…
New 5-year data from the EXCC pivotal trial:
The GORE® EXCLUDER® Conformable AAA Endoprosthesis shows 0% aneurysm-related mortality, no conversions, and no major endoleaks.
Safe. Durable. Effective—regardless of seal zone length. bit.ly/43PlW89
Today the first total percutaneous 3 vessel Endovascular arch repair of the Americas was done at UT Health Houston - Memorial Hermann Heart and Vascular Institute. Thx for all support from our multi-specialty team, Cook Medical and GE healthcare. New chapter is written in Houston
Today’s endovascular specialists face distinct challenges when treating patients with below-the-knee peripheral arterial disease. Our goal is to serve as a procedural partner by providing physicians w/tools to access, target & treat this complex disease. bit.ly/2HTopY1